Belgrade

As a rising powerhouse in Southeast Europe, Belgrade has rapidly transformed into a premier destination for life sciences investment and healthcare innovation.

The city is most recognized for its visionary BIO4 Campus, a €450 million greenfield project that integrates biotechnology, biomedicine, bioinformatics and artificial intelligence into a single, high-tech ecosystem.

Belgrade’s pharmaceutical sector is bolstered by long-standing giants like Hemofarm, supporting a robust domestic market while expanding pharmaceutical manufacturing and export capabilities across the region.

The city’s academic research prestige is anchored by the University of Belgrade, which consistently ranks as a top global institution for clinical medicine, public health and biomedical sciences.

Strategic public-private partnerships and foreign direct investment (FDI) have accelerated the growth of the medical device industry, focusing on smart medical technologies and diagnostic imaging.

Belgrade’s commitment to digital health is evidenced by its advanced health-IT infrastructure, which gained international acclaim for its data-driven pandemic response.

The local biotech startup scene thrives within the Science Technology Park Belgrade, providing a fertile environment for translational research and early-stage clinical trials.

With a deep talent pool of STEM professionals and increasing alignment with EU regulatory standards, Belgrade offers a cost-effective, high-quality landscape for global life sciences companies.

As a regional innovation hub, the city continues to drive advancements in genomics, personalized medicine and AI-driven drug discovery.